# Expanded Access of Vigil in Solid Tumors

> **NCT03842865** · — · TEMPORARILY_NOT_AVAILABLE · sponsor: **Gradalis, Inc.**

## Conditions studied

- Solid Tumor
- Ewing Sarcoma
- Ewing's Tumor Metastatic
- Ewing's Sarcoma Metastatic
- Advanced Gynecological Cancers
- Ovarian Cancer
- Cervical Cancer
- Uterine Cancer

## Interventions

- **BIOLOGICAL:** Vigil

## Key facts

- **NCT ID:** NCT03842865
- **Lead sponsor:** Gradalis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** TEMPORARILY_NOT_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03842865

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03842865, "Expanded Access of Vigil in Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03842865. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*